Viewing Study NCT05443334


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 11:14 PM
Study NCT ID: NCT05443334
Status: COMPLETED
Last Update Posted: 2025-09-24
First Post: 2022-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module